4CPS-051 Cost saving impact of biosimilar trastuzumab for the treatment of HER-2 positive breast cancer in a hospital
Paradas Palomo, JD, Del Rio Valencia, JC, Tamayo Bermejo, R, Muñoz Castillo, I, Martin Clavo, S, Mora Rodriguez, B, Espinosa Bosch, M
Published in European journal of hospital pharmacy. Science and practice (20.03.2024)
Published in European journal of hospital pharmacy. Science and practice (20.03.2024)
Get full text
Journal Article
4CPS-110 Safety and effectiveness of obinutuzumab in chronic lymphocytic leukaemia: our experience
Fernandez Cuerva, C, Ortega de la Cruz, C, del Rio Valencia, JC, Mora Rodriguez, B, Muñoz Castillo, I
Published in European journal of hospital pharmacy. Science and practice (01.03.2019)
Published in European journal of hospital pharmacy. Science and practice (01.03.2019)
Get full text
Journal Article
5PSQ-137 Analysis of the dpyd gene mutations in cancer patients who are candidates for treatment with fluoropyrimidines
Tamayo Bermejo, R, Mora Rodríguez, B, Espinosa Bosch, M, Muñoz Castillo, IM
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Get full text
Journal Article
4CPS-276 Atezolizumab in non-small cell lung cancer: effectiveness and safety real world data study
Alcaraz Sanchez, JJ, Del Rio Valencia, JC, Pintado Álvarez, A, Mora Rodríguez, B, Muñoz Castillo, I
Published in European journal of hospital pharmacy. Science and practice (01.03.2021)
Published in European journal of hospital pharmacy. Science and practice (01.03.2021)
Get full text
Journal Article
4CPS-102 Analysis of off-label use in onco-haematology
Lorenzo, M Gutiérrez, Cuerva, C Fernández, Rodríguez, B Mora
Published in European journal of hospital pharmacy. Science and practice (01.03.2018)
Published in European journal of hospital pharmacy. Science and practice (01.03.2018)
Get full text
Journal Article
4CPS-099 Real world evidence of pembrolizumab as monotherapy in non-small cell lung cancer: effectiveness and safety study
Tamayo Bermejo, R, Del Río Valencia, JC, Mora Rodríguez, B, Muñoz Castillo, I
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Get full text
Journal Article
4CPS-087 The use of patient-reported outcome instruments in immune checkpoint inhibitor therapy for cancer in clinical practice: a systematic review
Espinosa-Bosch, M, Mora-Rodriguez, B, Tamayo-Bermejo, R, Muñoz-Castillo, I
Published in European journal of hospital pharmacy. Science and practice (23.03.2022)
Published in European journal of hospital pharmacy. Science and practice (23.03.2022)
Get full text
Journal Article
PS-108 Study of potential drug interactions with oral antineoplastic agents in an oncology outpatient clinic
Mora Rodríguez, B, Ruiz de Villegas, M, Tamayo Bermejo, R, Muñoz Castillo, M
Published in European journal of hospital pharmacy. Science and practice (01.03.2015)
Published in European journal of hospital pharmacy. Science and practice (01.03.2015)
Get full text
Journal Article
Targeted anticancer treatments
Toca-Muñoz, M., Mora-Rodríguez, B., Luna-Higuera, A., Alcalá, E. Valverde, Muñoz-Castillo, I.M.
Published in European journal of hospital pharmacy. Science and practice (01.04.2012)
Published in European journal of hospital pharmacy. Science and practice (01.04.2012)
Get full text
Journal Article